Valuation : QHSLab, Inc.

Market Cap 48.1L 41.5L 39.28L 35.59L 66.72L 46Cr 67.19L 4.65Cr 1.79Cr 23Cr 1.81Cr 1.77Cr 74Cr P/E 2024
-8.27x
P/E 2025 30.3x
Enterprise Value 44.67L 38.54L 36.48L 33.05L 61.95L 43Cr 62.4L 4.32Cr 1.66Cr 22Cr 1.68Cr 1.64Cr 69Cr EV / Sales 2024
1.97x
EV / Sales 2025 2.41x
Free-Float
66.08%
Yield 2024 *
-
Yield 2025 -
1 day-24.24%
1 week+42.86%
Current month+42.05%
1 month+42.86%
3 months+100.00%
6 months-24.47%
Current year-17.48%
1 week 0.32
Extreme 0.32
0.5
1 month 0.3
Extreme 0.3
0.5
Current year 0.23
Extreme 0.233
1.14
1 year 0.08
Extreme 0.08
1.14
3 years 0.02
Extreme 0.0155
1.14
5 years 0.02
Extreme 0.0155
1.14
10 years 0
Extreme 0.005
1.14
Manager TitleAgeSince
Chief Executive Officer 49 28/06/2016
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 02/05/2024
Director TitleAgeSince
Chairman 49 28/06/2016
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Héritage -22,26,280 14.8095%
31/12/25 Others

Chief Executive Officer

26,44,424 100.0000%
31/12/25 Conversion

Chief Executive Officer

2,13,075 1.8887%
Change 5-day change 1-year change 3-year change Capi.($)
-24.24%+42.86%+212.50%+614.29% 48.1L
+1.10%-0.65%+27.19%+19.34% 23TCr
-0.19%-3.62%+5.31%-19.41% 14TCr
+2.41%+0.67%-17.91%+22.42% 13TCr
-0.28%-10.08%-58.15%-19.54% 6.23TCr
-0.49%-1.97%-19.72%-15.81% 4.94TCr
-2.77%-6.15%+8.77%+14.99% 4.86TCr
+2.66%-2.61%+19.22%+30.28% 4.14TCr
+1.67%-0.25%+38.24%+56.84% 4.01TCr
-0.60%-4.41%-19.20%+46.52% 3.12TCr
Average -2.07%-3.08%+19.62%+74.99% 7.7TCr
Weighted average by Cap. +0.67%-2.50%+2.73%+10.75%

Financials

2024 2025
Net sales 21.32L 18.39L 17.41L 15.77L 29.57L 20Cr 29.78L 2.06Cr 79.42L 10Cr 80.03L 78.29L 33Cr 26.92L 23.22L 21.98L 19.91L 37.33L 26Cr 37.6L 2.6Cr 1Cr 13Cr 1.01Cr 98.85L 41Cr
Net income -3L -2L -2L -2L -4L -2.48Cr -4L -25.05L -10L -1.26Cr -10L -10L -3.98Cr 5L 4L 4L 3L 6L 4.37Cr 6L 44.2L 17.04L 2.22Cr 17.17L 16.8L 7.03Cr
Net Debt 15.79L 13.62L 12.89L 11.68L 21.9L 15Cr 22.05L 1.53Cr 58.81L 7.67Cr 59.27L 57.98L 24Cr -3L -3L -3L -3L -5L -3.28Cr -5L -33.17L -12.79L -1.67Cr -12.89L -12.61L -5.27Cr
Logo QHSLab, Inc.
QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.
Employees
12
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. USAQ Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!